Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Ohio for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Ohio only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Ohio (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Brian Murphy (NPI 1104877125)

Field	Value
Entity Type	Individual
Organization	Brian Murphy
Address	417 Quarry Lakes Drive
City	Sandusky
State	OH
ZIP	44870
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	May 15, 2006

Payer Source	Total Paid
Medicare	$2.8M
Medicaid	$0

Key Findings

This provider’s Medicare revenue is highly concentrated: the precomputed top three Medicare codes account for 91.1% of the provider’s total Medicare revenue, led by J9271 ($2.3M, 83.5%), followed by J0897 ($117.4K, 4.3%) and 99214 ($90K, 3.3%). Such a skew toward a small set of codes indicates that a very narrow set of services—rather than a broad mix of primary care or diagnostic procedures—drives the practice’s financial profile.

The code mix and descriptions indicate an infusion-centered hematology/oncology practice: high revenue from J9271 (pembrolizumab) and meaningful billing for chemotherapy administration codes such as 96413 and add-ons like 96417 and 96415. These patterns are consistent with an operation that administers systemic cancer therapies and supportive biologics on-site rather than a visit-only model.

J9271 stands out as an extreme statistical outlier nationally: 53K claims, $43 avg paid/claim, $2.3M revenue and ranked #14 of 1841 providers nationally (99th percentile; extreme outlier, far above typical national volume for this code). This ranking signals that the provider is a major national outlier in pembrolizumab administration volume and is operating at a scale for this drug that few peers match.

Other service and visit activity shows elevated but less extreme concentrations: 99214 (1K claims, $87 avg paid/claim, $90K revenue) ranks #10531 of 479517 providers nationally (98th percentile; notably above typical national volume), and 96413 (592 claims, $95 avg paid/claim, $56.2K revenue) ranks #429 of 7514 providers nationally (94th percentile; notably above typical national volume). These positions indicate the provider performs a higher-than-typical number of moderate-complexity E/M visits and chemotherapy administrations relative to peers.

Several injectable and biologic codes show typical volume and modest revenue contribution, including J0897 (6.2K claims, $19 avg paid/claim, $117.4K revenue) which ranks #2218 of 10057 providers nationally (78th percentile; typical, unremarkable volume), and J0881 (31.8K claims, $2 avg paid/claim, $63.6K revenue) which ranks #160 of 1114 providers nationally (86th percentile; typical, unremarkable volume). These items appear to be routine supportive or adjunctive therapies that complement the high-volume oncology infusions.

Payer mix is effectively single-payer Medicare: lifetime Medicare revenue is $2.8M while Medicaid shows none on file, so the practice’s reported public-payer exposure is concentrated entirely in Medicare. The absence of Medicaid billing limits assessment of the provider’s exposure to state programs and suggests any Medicaid-based contracting or risk would be minimal or absent in the available data.

Average paid-per-claim figures emphasize a unit-pricing pattern typical for oncology drugs (per-mg billing): J9271 shows $43 avg paid/claim despite very large total revenue driven by 53K claims, J0897 shows $19 avg paid/claim, and J0881 shows $2 avg paid/claim. This combination of low per-claim payments and very high claim counts is consistent with drugs billed in small dosing units rather than high-dollar single-injection charges, and it explains how large aggregate revenue can be concentrated in a single drug code.

The provider has long tenure in the NPI registry, enumerated 2006-05-15 (~20 years ago), which aligns with an established practice profile and sustained service lines. Given the extremely high reliance on J9271 (83.5% of Medicare revenue) and the concentration of revenue in a few codes, the practice faces operational and revenue concentration exposure if utilization patterns or reimbursement for those key drugs change.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

44 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	53,010	$40	$2.3M
J0897	Injection, denosumab, 1 mg	6,180	$20	$117.4K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,030	$90	$90K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	31,800	$1	$63.6K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	590	$100	$56.2K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	360	$80	$29.9K
J1437	Injection, ferric derisomaltose, 10 mg	1,700	$20	$28.9K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	110	$130	$14.5K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	140	$50	$6.5K
96375	Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the…	560	$10	$6.1K

Showing 1–10 of 44

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 44 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Ohio Distribution

Brian Murphy — 5 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Ohio

Full comparison — all codes billed, vs. state median

44 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	1	40	12,100	$40	$603K
J0897	40	230	2,880	$20	$79.5K
J3490	16	50	100	$560	$73.1K
J2506	7	10	480	$80	$49.8K
J0881	2	20	14,800	$1	$36.6K
J1437	9	20	1,700	$20	$34.9K
J9217	59	100	120	$130	$22.3K
96413	7	210	130	$90	$16.8K
99214	118	20,010	100	$70	$11.7K
96401	39	60	90	$50	$7K

Showing 1–10 of 44

Related Providers

Other providers that share a Tax Identification Number (TIN) with Brian Murphy, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
The Cleveland Clinic Foundation	OH	General Acute Care Hospital	$0	$864.1M
Ohiohealth Corporation	OH	Family Medicine Physician	$0	$89.1M
Columbus Radiology Corp	OH	Diagnostic Radiology Physician	$0	$49.9M
Partners Physician Group	OH	Surgery Physician	$0	$28.5M
Quick Med Urgent Care LLC	OH	Urgent Care Clinic/Center	$0	$21.8M
Clinic Medical Services Company LLC	OH	Diagnostic Radiology Physician	$0	$10.8M
Cleveland Clinic Home Care Services	OH	Community Based Hospice Care Agency	$0	$10.8M
The Cleveland Clinic Foundation	OH	Clinical Medical Laboratory	$144K	$9M
Wooster Clinic, LLC	OH	Multi-Specialty Clinic/Center	$0	$6.9M
Community Memorial Hospital Association	MN	Critical Access Hospital	$0	$4.3M

Nearby Providers

Other providers in the same ZIP code as Brian Murphy, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Firelands Regional Medical Center	OH	General Acute Care Hospital	$0	$37.5M
Cambridge Home Health Care, Inc.	OH	Home Health Agency	$0	$19.4M
Firelands Regional Medical Center	OH	Multi-Specialty Clinic/Center	$0	$17.5M
Northern Ohio Medical Specialists LLC	OH	Internal Medicine Physician	$0	$16.4M
Stein Hospice Services, Inc	OH	Community Based Hospice Care Agency	$0	$11.1M
Erie County Office Of Auditor	OH	Federally Qualified Health Center (FQHC)	$0	$7.5M
Erie County Office Of Auditor	OH	Substance Use Disorder Rehabilitation Hospital Unit	$0	$7M
Family Health Services Of Erie County	OH	Federally Qualified Health Center (FQHC)	$0	$6.9M
Sandusky City Office Of Treasurer	OH	Land Ambulance	$345.9K	$1.1M
Surgery Center Of Sandusky LLC	OH	Ambulatory Surgical Clinic/Center	$974.7K	$0

Brian Murphy — Billing Profile & Reimbursement Data

Sign up for Brian Murphy — Billing Profile & Reimbursement Data policy alerts

Brian Murphy — Billing Profile & Reimbursement Data

Sign up for Brian Murphy — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References